A biological assay was used to determine the potency of adrenaline solution 1 in 10 000 soon after manufacture and again after storage at room temperature for 1 year. No deterioration in potency was observed.
The stability of adrenaline solutions which are more dilute than 0.1% has always been of concern. Presumably this is the reason that neither the British Pharmacopoea nor the United States Pharmacopea contains a formula for adrenaline solutions that are more dilute than 1 in 1000. This concern, about the storage potential of adrenaline solution 1 in 10000 prompted the present investigation.
The laevo isomer of adrenaline is 15 times more potent than the dextro isomer (Harper, 1975) and it is impossible using a chemical assay to distinguish these two isomers. For this reason a biological method was used to assess the potency of adrenaline.
MATERIALS AND METHOD
In May 1981 the potency of recently manufactured adrenaline solution 1 in 10 000 was compared with a standard solution of adrenaline 1 in 10000. The standard solution of adrenaline was prepared by thoroughly mixing 1 ml of recently manufactured adrenaline 1 in 1000 with 9 ml of normal saline.
Technique of biological assay
A 30-kg mongrel dog was anaesthetized by injecting 900 mg of a 60-mg ml" 1 solution of sodium pentobarbitone to a fore-limb vein. The trachea was intubated and the lungs ventilated with air using a Palmer large animal ventilator. Electrocardiograph needles were positioned and the ECG was recorded on a two-channel Grass Model 79 chart recorder (Grass Instrument Co., Quincy, Mass., U.S.A.).
The right femoral artery and femoral vein were exposed and cannulated. Arterial pressure (Statham P23 AA pressure transducer), was displayed on the second channel of the Grass Model 79 chart recorder. Fluids were infused and drugs administered via the femoral vein cannula.
The experimental method used to determine the potency of the adrenaline solution 1 in 10000 was a modification of the procedure described for the biological testing of pressor substances in the United States Pharmacopea (Pharmacopea, 1960) .
Storage of ampoules
Two ampoules of adrenaline 1 in 10000 from the same batch as the ampoule which had been assayed were placed in the theatre drug cupboard and stored at room temperature for 12 months.
Repeat assay
In May 1982 the potency of one of the stored ampoules was compared with a freshly prepared standard solution of adrenaline.
RESULTS
The recordings of arterial pressure following the administration i.v. of both the test and the standard adrenaline solution are presented in figure 1 . The results from the two assays are shown in table I. 
DISCUSSION
Adrenaline 1 in 1000 B.P. has been shown to be stable at room temperature for more than 6yr (West, 1950) . There has been only one previous study investigating the viable shelf-life of adrenaline solution 1 in 10000 (Report, 1964) . It was found that, after 5 weeks storage at 37 °C, adrenaline solution 1 in 10 000 had lost 6% of its original potency.
In the present investigation a solution of adrenaline 1 in 10000 was assayed shortly after manufacture and again after storage at an average temperature of 19°C (range 13-26°C) for 12 months. No deterioration in potency was found.
